XOMA Corporation (XOMAP) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jun 18Jun 24Jun 29Jul 2Jul 8Jul 13Jul 16Jul 21

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

$24.58M

MomentumView details →

1D Return

+0.00%

YTD Return

−7.03%

RSI (14)

28.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.5x

Market Cap

$24.58M

RSI (14)

28.8

MomentumView details →

1D Return

+0.00%

YTD Return

−7.03%

ProfitabilityView details →

Gross Margin

94.35%

Net Margin

123.34%

EBITDA Margin

184.29%

ROE (TTM)

29.95%

ROA (TTM)

12.44%

Asset Turnover

0.10x

GrowthView details →

Revenue YoY

−36.12%

EPS YoY

+468.97%

FCF YoY

+199.24%

Revenue CAGR 3Y

+105.30%

EPS CAGR 3Y

+192.73%

EBITDA YoY

+315.28%

EarningsView details →

EPS (Actual)

$0.18

EPS Surprise

7.33%

Beats (12Q)

4/12

Next Q EPS Est

—

Avg Surprise (4Q)

740.12%

Rev Surprise

−11.45%

Capital & dividendView details →

Debt/Equity

1.10x

Current Ratio

3.59x

Quick Ratio

3.59x

Div Yield

4.32%

Div Rate

$1.08

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

27.41M

Net Income (TTM)

33.81M

Op. CF (TTM)

6.63M

Latest newsMore news →

Ligand Pharmaceuticals completed its acquisition of XOMA Royalty Corporation.53d ago

XOMA Royalty Corporation announced the redemption of its Perpetual Preferred Stock.84d ago

Similar companies

Lantern Pharma Inc.LTRN Atossa Therapeutics, Inc.ATOS BeyondSpring Inc.BYSI Tvardi Therapeutics, Inc.TVRD ABVC BioPharma, Inc.ABVC Jasper Therapeutics, Inc.JSPR Find similar companies →

Latest newsMore news →

Ligand Pharmaceuticals completed its acquisition of XOMA Royalty Corporation.53d ago XOMA Royalty Corporation announced the redemption of its Perpetual Preferred Stock.84d ago XOMA Royalty Corporation declared a quarterly cash dividend on its Series A Cumulative Perpetual Preferred Stock.84d ago